Imprimer

(+/-)-Equol ≥98% (par HPLC, TLC)

Marques : Enzo Life Sciences
Ratings: Ecrire un avis

Total Evaluation: 0
Moyenne des Notes : 0.0 sur 5

ALEXALX385032M005EA 67.5 EUR
ALEXALX385032M005 ALEXALX385032M025
(+/-)-Equol ≥98% (par HPLC, TLC)
(+/-)-Equol

Flavonoid. Racemic mixture. Urinary metabolite of daidzein. Inhibits 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 signalling pathway. Shows positive effects on the incidence of prostate cancer and physiological changes after menopause. Functions as a DHT blocker. Preferentially activates estrogen receptor β (ERβ).


  • Metabolite of daidzein


Flavonoid. Racemic mixture. Urinary metabolite of daidzein. Inhibits 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 signalling pathway. Shows positive effects on the incidence of prostate cancer and physiological changes after menopause. Functions as a DHT blocker. Preferentially activates estrogen receptor beta (ERbeta).


White to light yellow crystalline solid.


Soluble in DMSO, methanol or 100% ethanol; insoluble in water.

Formule: C₁₅H₁₄O₃
Poids moléculaire: 242,27 g/mol
Température de stockage: Congélateur
Numéro MDL: MFCD00016662
Numéro CAS: 94105-90-5
https://fr.vwr.com/stibo/web/std.lang.all/05/86/45390586.jpg

Commander maintenant

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Plus About VWR